BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 16344403)

  • 1. nNOS gene deletion exacerbates pathological left ventricular remodeling and functional deterioration after myocardial infarction.
    Dawson D; Lygate CA; Zhang MH; Hulbert K; Neubauer S; Casadei B
    Circulation; 2005 Dec; 112(24):3729-37. PubMed ID: 16344403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Critical role of the NAD(P)H oxidase subunit p47phox for left ventricular remodeling/dysfunction and survival after myocardial infarction.
    Doerries C; Grote K; Hilfiker-Kleiner D; Luchtefeld M; Schaefer A; Holland SM; Sorrentino S; Manes C; Schieffer B; Drexler H; Landmesser U
    Circ Res; 2007 Mar; 100(6):894-903. PubMed ID: 17332431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multi-parameter in vivo cardiac magnetic resonance imaging demonstrates normal perfusion reserve despite severely attenuated beta-adrenergic functional response in neuronal nitric oxide synthase knockout mice.
    Vandsburger MH; French BA; Helm PA; Roy RJ; Kramer CM; Young AA; Epstein FH
    Eur Heart J; 2007 Nov; 28(22):2792-8. PubMed ID: 17602202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deficiency of neuronal nitric oxide synthase increases mortality and cardiac remodeling after myocardial infarction: role of nitroso-redox equilibrium.
    Saraiva RM; Minhas KM; Raju SV; Barouch LA; Pitz E; Schuleri KH; Vandegaer K; Li D; Hare JM
    Circulation; 2005 Nov; 112(22):3415-22. PubMed ID: 16301341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Borderzone contractile dysfunction is transiently attenuated and left ventricular structural remodeling is markedly reduced following reperfused myocardial infarction in inducible nitric oxide synthase knockout mice.
    Gilson WD; Epstein FH; Yang Z; Xu Y; Prasad KM; Toufektsian MC; Laubach VE; French BA
    J Am Coll Cardiol; 2007 Oct; 50(18):1799-807. PubMed ID: 17964046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-monocyte chemoattractant protein-1 gene therapy attenuates left ventricular remodeling and failure after experimental myocardial infarction.
    Hayashidani S; Tsutsui H; Shiomi T; Ikeuchi M; Matsusaka H; Suematsu N; Wen J; Egashira K; Takeshita A
    Circulation; 2003 Oct; 108(17):2134-40. PubMed ID: 14517168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuronal nitric oxide synthase protects against myocardial infarction-induced ventricular arrhythmia and mortality in mice.
    Burger DE; Lu X; Lei M; Xiang FL; Hammoud L; Jiang M; Wang H; Jones DL; Sims SM; Feng Q
    Circulation; 2009 Oct; 120(14):1345-54. PubMed ID: 19770398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of myocardial neuronal nitric oxide synthase-derived nitric oxide in beta-adrenergic hyporesponsiveness after myocardial infarction-induced heart failure in rat.
    Bendall JK; Damy T; Ratajczak P; Loyer X; Monceau V; Marty I; Milliez P; Robidel E; Marotte F; Samuel JL; Heymes C
    Circulation; 2004 Oct; 110(16):2368-75. PubMed ID: 15466641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased cardiac adenylyl cyclase expression is associated with increased survival after myocardial infarction.
    Takahashi T; Tang T; Lai NC; Roth DM; Rebolledo B; Saito M; Lew WY; Clopton P; Hammond HK
    Circulation; 2006 Aug; 114(5):388-96. PubMed ID: 16864723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concentric left ventricular remodeling in endothelial nitric oxide synthase knockout mice by chronic pressure overload.
    Ruetten H; Dimmeler S; Gehring D; Ihling C; Zeiher AM
    Cardiovasc Res; 2005 Jun; 66(3):444-53. PubMed ID: 15914109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin converting enzyme inhibitor prevents left ventricular remodelling after myocardial infarction in angiotensin II type 1 receptor knockout mice.
    Yoshiyama M; Nakamura Y; Omura T; Izumi Y; Matsumoto R; Oda S; Takeuchi K; Kim S; Iwao H; Yoshikawa J
    Heart; 2005 Aug; 91(8):1080-5. PubMed ID: 16020603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biglycan is required for adaptive remodeling after myocardial infarction.
    Westermann D; Mersmann J; Melchior A; Freudenberger T; Petrik C; Schaefer L; Lüllmann-Rauch R; Lettau O; Jacoby C; Schrader J; Brand-Herrmann SM; Young MF; Schultheiss HP; Levkau B; Baba HA; Unger T; Zacharowski K; Tschöpe C; Fischer JW
    Circulation; 2008 Mar; 117(10):1269-76. PubMed ID: 18299507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of glutathione peroxidase prevents left ventricular remodeling and failure after myocardial infarction in mice.
    Shiomi T; Tsutsui H; Matsusaka H; Murakami K; Hayashidani S; Ikeuchi M; Wen J; Kubota T; Utsumi H; Takeshita A
    Circulation; 2004 Feb; 109(4):544-9. PubMed ID: 14744974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are myocardial eNOS and nNOS involved in the beta-adrenergic and muscarinic regulation of inotropy? A systematic investigation.
    Martin SR; Emanuel K; Sears CE; Zhang YH; Casadei B
    Cardiovasc Res; 2006 Apr; 70(1):97-106. PubMed ID: 16545353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of mitochondrial peroxiredoxin-3 prevents left ventricular remodeling and failure after myocardial infarction in mice.
    Matsushima S; Ide T; Yamato M; Matsusaka H; Hattori F; Ikeuchi M; Kubota T; Sunagawa K; Hasegawa Y; Kurihara T; Oikawa S; Kinugawa S; Tsutsui H
    Circulation; 2006 Apr; 113(14):1779-86. PubMed ID: 16585391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased mortality and aggravation of heart failure in estrogen receptor-beta knockout mice after myocardial infarction.
    Pelzer T; Loza PA; Hu K; Bayer B; Dienesch C; Calvillo L; Couse JF; Korach KS; Neyses L; Ertl G
    Circulation; 2005 Mar; 111(12):1492-8. PubMed ID: 15781739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of a cleavage-resistant collagen mutation on left ventricular remodeling.
    Lindsey ML; Yoshioka J; MacGillivray C; Muangman S; Gannon J; Verghese A; Aikawa M; Libby P; Krane SM; Lee RT
    Circ Res; 2003 Aug; 93(3):238-45. PubMed ID: 12855673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transgenic alpha1A-adrenergic activation limits post-infarct ventricular remodeling and dysfunction and improves survival.
    Du XJ; Gao XM; Kiriazis H; Moore XL; Ming Z; Su Y; Finch AM; Hannan RA; Dart AM; Graham RM
    Cardiovasc Res; 2006 Sep; 71(4):735-43. PubMed ID: 16859660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postinfarction treatment with an adenoviral vector expressing hepatocyte growth factor relieves chronic left ventricular remodeling and dysfunction in mice.
    Li Y; Takemura G; Kosai K; Yuge K; Nagano S; Esaki M; Goto K; Takahashi T; Hayakawa K; Koda M; Kawase Y; Maruyama R; Okada H; Minatoguchi S; Mizuguchi H; Fujiwara T; Fujiwara H
    Circulation; 2003 May; 107(19):2499-506. PubMed ID: 12695295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous evaluation of infarct size and cardiac function in intact mice by contrast-enhanced cardiac magnetic resonance imaging reveals contractile dysfunction in noninfarcted regions early after myocardial infarction.
    Yang Z; Berr SS; Gilson WD; Toufektsian MC; French BA
    Circulation; 2004 Mar; 109(9):1161-7. PubMed ID: 14967719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.